Review Article
Novel Biomarkers for Alzheimer’s Disease: Plasma Neurofilament Light and Cerebrospinal Fluid
Table 1
Molecules that showed differential levels in CSF from Alzheimer’s disease patients as compared to controls.
| Protein | Up/downregulated |
| Albumin | ↑ | Amyloid β A4 protein | ↑ | Apolipoprotein AI | ↑ | Apolipoprotein AII | ↑ | Apolipoprotein E | ↑ | BACE 1 | ↑ | 24S-Hydroxycholesterol | ↑ | C3a | ↑ | C4a | ↑ | Cystatin C | ↑ | Cystatin C, 8 amino acid N-terminal truncation | ↑ | Immunoglobulin heavy chain | ↓ | Leucine-rich repeat-containing protein 4B | ↑ | Leucine-rich repeat-containing protein 4B | ↓ | N-acetyllactosamine | ↓ | Neuronal pentraxin-1 | ↑ | Prostaglandin-H2 D-isomerase | ↑ ↓ | Retinol-binding protein | ↑ | Thioredoxin | ↑ | Transthyretin | ↓ ↑ ↓ | VGF | ↑ | a-1-Antitrypsin | ↑ | α-1β glycoprotein | ↑ | α-2HS glycoprotein | ↓ | β fibrinogen | ↑ | β-2-Microglobulin | ↓ |
|
|